GE HealthCare Technologies (GEHC) Change in Cash (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Change in Cash of -$2.2 billion for Q1 2026, down 558.23% on a QoQ basis from $486.0 million in Q4 2025, and down 435.34% year-over-year from $664.1 million in Q1 2025.
GE HealthCare Technologies (GEHC) Change in Cash (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Change in Cash history runs 5 years deep, the most recent figure standing at -$2.2 billion for Q1 2026.
- Quarterly Change in Cash fell 435.34% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$188.0 million (down 113.64% YoY) and the FY2025 annual result came in at $1.6 billion, up 319.38% from the prior year.
- Change in Cash was -$2.2 billion for Q1 2026 at GE HealthCare Technologies, down from $486.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $1.6 billion in Q3 2024 and bottomed at -$2.2 billion in Q1 2026.
- A 5-year average of $101.6 million and a median of $59.0 million in 2024 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 1926.92% in 2023, while the deepest fall reached 1720.83% in 2023.
- GE HealthCare Technologies' Change in Cash stood at $947.0 million in 2022, then plunged by 90.92% to $86.0 million in 2023, then slumped by 889.53% to -$679.0 million in 2024, then jumped by 171.58% to $486.0 million in 2025, then tumbled by 558.23% to -$2.2 billion in 2026.
- Business Quant data shows GEHC's Change in Cash at -$2.2 billion in Q1 2026, $486.0 million in Q4 2025, and $264.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.72 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.13 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 803.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -504.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -492.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.23 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.23 Bn |
| Dec 31, 2025 | 486.00 Mn |
| Sep 30, 2025 | 264.00 Mn |
| Jun 30, 2025 | 1.29 Bn |
| Mar 31, 2025 | -416.00 Mn |
| Dec 31, 2024 | -679.00 Mn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | -547.00 Mn |
| Mar 31, 2024 | 59.00 Mn |
| Dec 31, 2023 | 86.00 Mn |
| Sep 30, 2023 | 475.00 Mn |
| Jun 30, 2023 | -389.00 Mn |
| Mar 31, 2023 | 883.00 Mn |
| Dec 31, 2022 | 947.00 Mn |
| Sep 30, 2022 | -26.00 Mn |
| Jun 30, 2022 | 24.00 Mn |
| Mar 31, 2022 | -55.00 Mn |